Formerly known in English as Sinomune, the company introduces a renewed international identity to support its global development

Wuxi, China — Ziyond Pharmaceutical Co., Ltd. (“ZIYOND Pharma”) today announced that its English name has been updated from Sinomune Pharmaceutical Co., Ltd. to Ziyond Pharmaceutical Co., Ltd., effective May 26, 2026. Together with a refreshed visual identity, the new English name marks an important step in the company’s global development strategy and reflects its commitment to building a clearer, more unified, and more recognizable international brand.

As ZIYOND Pharma continues to strengthen its focus on dermatology pharmaceuticals and science-based skincare solutions, the updated English name is designed to support broader international communication, collaboration, and market engagement. The company will continue to focus on skin health and dermatological innovation while exploring expanded opportunities for global cooperation.

The English name update does not affect ZIYOND Pharma’s existing business operations, product quality standards, or service commitments. During the transition period, certain legacy materials may continue to reference Sinomune, while the new English name and visual identity will be gradually applied across corporate materials, product packaging, digital platforms, and related brand assets, where applicable and in accordance with relevant regulatory requirements.

“The adoption of ZIYOND as our English name marks an important milestone as we build on our strong domestic foundation and engage more actively with the global market,” said Xu Jun, Chairman of ZIYOND Pharma. “Through a clearer and more open international identity, we look forward to deepening communication and collaboration with partners worldwide.”

The name ZIYOND was developed to be distinctive, memorable, and easier to recognize in international markets. The suffix “YOND” echoes the idea of going “beyond,” conveying continuous progress, scientific advancement, and the pursuit of excellence, while the letter “Y” suggests youthful energy, forward momentum, and an innovative spirit.

Alongside the name update, ZIYOND Pharma has introduced a refreshed visual identity system, including its logo, auxiliary graphics, typography, and signature color palette. Inspired by the application and absorption characteristics of topical dermatological products, the visual system uses a circular permeation motif to symbolize targeted delivery, nourishment, and ongoing protection for the skin.

The signature ZIYOND Green combines the vitality of green with warm undertones, presenting a brand image that is professional, science-driven, and approachable. Together, the new name and visual identity express ZIYOND Pharma’s commitment to dermatological science, patient-centered care, and long-term international growth.

“This brand refresh is a systematic refinement of our corporate culture, core values, and brand story,” said Xie Hongwei, CEO of ZIYOND Pharma. “Moving forward, ZIYOND Pharma will continue to safeguard skin health through the combined strengths of technology, quality, and branding, while entering the global market with a more distinctive and trusted brand presence.”

About ZIYOND Pharma

Ziyond Pharmaceutical Co., Ltd., formerly known in English as Sinomune Pharmaceutical Co., Ltd., is a dermatology-focused pharmaceutical company in China with over thirty years of dedication to the skin health sector. The company has developed a strong product portfolio, including LuoFu (洛芙^®), LiFu (丽芙^®), JinNiuer (金纽尔^®), and Zrvive (质润^®), addressing areas such as fungal infections, acne, inflammatory skin diseases, and scalp disorders.

ZIYOND Pharma operates a national postdoctoral research station, a CNAS-certified laboratory, and several provincial R&D platforms. Moving forward, the company will continue to advance its “Technology + Marketing” dual-drive strategy, expand its product coverage, enrich its product lines, accelerate global development, and strengthen its presence in the dermatology field.

For more information about ZIYOND Pharma, company updates, product offerings, and potential cooperation opportunities, please visit www.ziyondpharma.com.